Welcome to LustgartenLIVE!
a new quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer
. Moderated by Andrew Rakeman, PhD , Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations.
REGISTRATION IS NOW OPEN
for From the Lab to You: Clinical Advances
Clinical trials are designed to find more effective treatments than those currently available and provide a unique opportunity to better understand human disease. Clinical trials are especially important for pancreatic cancer patients, given the limited treatment options currently available. However, currently fewer than 5% of pancreatic cancer patients are enrolled in clinical trials. The Lustgarten Foundation is working to improve clinical trial participation by moving promising therapies into trials as quickly as possible, with the goal of having trials available for patients at every stage of the disease.
During this webinar, two world-renowned pancreatic cancer researchers and clinicians, Dr. Elizabeth Jaffee of Johns Hopkins and Dr. Brian Wolpin of the Dana-Farber Cancer Institute, explain the Foundation’s critical role in moving research from the lab to the clinic, advancing clinical trials and better therapies. The Foundation established the Clinical Accelerator Initiative (CAI) to shorten the time from clinical trial concept to launch using a Lustgarten-developed process based on the best available science. These “smarter” clinical trials will examine cutting-edge biomarkers to observe key indicators of how the treatment is working and will generate large volumes of data scientists can use now and in the future.